Skip to main content

Ahmed Shalaby, M.D.

Clinical Residents

Clinical Interest: My keen interest lies in patient-reported outcomes particularly in head & neck cancers. I’m driven to understand how these outcomes impact the lives of patients’ post-treatment, aiming to enhance their quality of life. Additionally, my passion extends to global oncology, where I aspire to bridge treatment gaps and improve care accessibility in underserved regions


Research Interest: I am deeply interested in clinical trials investigating the optimal sequence for combining radiation and immunotherapy, aiming to maximize treatment efficacy and survivorship


Publication List:

 Rikita I. Hatia , Madhulika Eluri , Ernest T. Hawk, Akram Shalaby, Elif Karatas, Ahmed Shalaby, Ahmed Abdelhakeem, Reham Abdel-Wahab, Ping Chang, Asif Rashid, Prasun K. Jalal, Christopher I. Amos, Younghun han, Tannaz Armaghany, Rachna T. Shroff, Donghui Li, Milind Javle, Manal M.Hassan Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity is Associated with Cholangiocarcinoma  Cancer Epidemiol Biomarkers Prev EPI-23-0388.

Sunyoung Lee, Rachna T Sheriff, Shalini Makawita, Lianchun Xiao , Anaemy Danner De Armas, Priya Bhosale, Kavitha Reddy, Ahmed Shalaby, Kanwal Raghav, Shubham Pant, Robert A wolff , Milind Javle Phase II Study of Ramucirumab in Advanced Biliary Tract Cancer Previously Treated by Gemcitabine-Based Chemotherapy, 2022       Clinical Cancer Research PMID: 35312753

Mindy X Wang , Jeffrey Guccione, brinda Rao Korivi, Mohamed E Abdelsalam, Sergio P Kilmkowski, Moataz Soliman, Ahmed S Shalaby, Khaled M Elsayes Gastrointestinal bleeding: imaging and interventions in cancer patients         BIR  2022  PMID: 35451853

Ahmed W. Moawad, David T. Fuentes, Mohamed G. ElBanan, Ahmed S. Shalaby, Jeffrey Guccione, Serageldin Kamel5, Corey T. Jensen, Khaled M. Elsayes Artificial Intelligence in Diagnostic Radiology: Where do we stand, challenges, and opportunities         JCAT    2022 PMID: 35027520

Abdel-Wahab R, Hassan MM, George B, Carmagnani Pestana R, Xiao L, Lacin S,Yalcin S, Shalaby, A., Al-Shamsi HO, Raghav K, Wolff RA, Yao JC, Girard L, Haque A, Dima S, Popescu I, Vauthey JN, Aloia TA, Tzeng CW, Chun YS, Rashid A, Morris JS, Amin HM, Kaseb AO. Impact of integrating insulin like growth factor-1 (IGF-1) in model for end stage liver disease (MELD) scores on predicting hepatocellular carcinoma patients’ survival. Journal of Oncology. 2020, Oct; 99(6): 321-32. Cited in PubMed; PMID: 33027788. Pub Status: Published.

Hassan, M.M., Botrus, G., Abdel-Wahab, R., Wolff, R.A., Li, D., Tweardy, D., Phan, A.T., Hawk, E., Javle, M., Lee, J.S., Torres, H.A., Rashid, A., Lenzi, R., Hassabo, H.M., Abaza, Y., Shalaby, A., Lacin, S., Morris, J., Patt, Y.Z., & Kaseb, A.O. Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma. Clin Gastroenterol Hepatology. 2017, Nov; 15(11): 1791-1799. Cited in PubMed; PMID: 28579181. Pub Status: Published.

Shalaby, A., Botrus, G., Kaseb, A.O., Li, D., Abdel-Wahab, R., Wolff, R.A., Lacin, S., Javle, M., Hawk, E., & Hassan, M. The Protective Effect of physical activity on Risk of Hepatocellular Carcinoma in USA. Journal of Clinical Oncology. 2017, May; 34(15): E-pub. Pub Status: Published.

Abdel-Wahab, R., Shehata, S., Hassan, M.M., Xiao, L., Lee, J.S., Cheung, S., Essa, H.H., Hassabo, H.M., Shalaby, A., Mosad, E., Raghav, K., Rashid, A., Wolff, R.A., Morris, J.S., Amin, H.M., & Kaseb, A.O. Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma. Oncotarget. 2015, Aug; 6(25): 21193-207. Cited in PubMed; PMID: 26098859. Pub Status: Published.

Al-Shamsi, H.O., Abdel-Wahab, R., Hassan, M.M., Shalaby, A., Dahbour, I., Lacin, S., Mahvash, A., Odisio, B.C., Murthy, R., Avritscher, R., Abdelsalam, M.E., Rashid, A., Vauthey, J.N., Aloia, T.A., Conrad, C., Chun, Y.S., Krishnan, S., & Kaseb, A.O. Natural History of T1N0M0 Hepatocellular Carcinoma: Large-Scale Study in the United States.. Oncology. 2017, Jul; 93(4): 233-242. Cited in PubMed; PMID: 28683459. Pub Status: Published.

Lacin, S., Abdel-Wahab, R., Elbanan, M., Abdelbaki, S., Shalaby, A., Hassan, M., Wei, W., Sun, J., Elsayes, K.M., & Kaseb, A.O. Impact of Sorafenib Treatment on Portal Hypertension in Hepatocellular Carcinoma Patients. Journal of Clinical Oncology. 2017, May; 34(15): E-pub. Pub Status: Published.

Abdel-Wahab, R., Hassan, M., Wolff, R.A., Lacin, S., Al-Shamsi, H.O., Raghav, K.P., Shalaby, A., Yao, J.C., & Kaseb, A.O. Association of elevated alpha-1 antitrypsin with advanced clinicopathologic features of hepatocellular carcinoma. Journal of Clinical Oncology. 2017, Mar; 35(4): 289-289. Pub Status: Published.

Botrus, G., Shalaby, A., Kaseb, A.O., Lenzi, R., Abdel-Wahab, R., Wolff, R.A., & Hassan, M. The protective effect of hormonal intake on risk of hepatocellular carcinoma in the United States. Journal of Clinical Oncology. 2017, Jan; 33(15): E-pub. Pub Status: Published.

Abdel-Wahab, R., Hassan, M., Lacin, S., Shalaby, A., Afshar-Kharghan, V., & Kaseb, A.O. Erythropoietin and hepatocellular carcinoma: What is patients survival outcome? Journal of Clinical Oncology. 2017, May; 35(15): E-pub. Pub Status: Published.

Mahvash, A., Murthy, R., Odisio, B.C., Raghav, K.P., Girard, L., Cheung, S., Nguyen, V., Ensor, J., Gadani, S., Elsayes, K.M., Abdel-Wahab, R., Hassan, H., Shalaby, A., Yao, J.C., Wallace, M.J., & Kaseb, A.O. Yttrium-90 resin microspheres as an adjunct to Sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatocell Carcinoma. 2016, Feb; 5(3): 1-7. Cited in PubMed; PMID: 27574586. Pub Status: Published.

Kaseb, A.O., Morris, J.S., Iwasaki, M., Al-Shamsi, H.O., Raghav, K.P., Girard, L., Cheung, S., Nguyen, V., Elsayes, K.M., Xiao, L., Abdel-Wahab, R., Shalaby, A., Hassan, M., Hassabo, H.M., Wolff, R.A., & Yao, J.C. Phase II trial of bevacizumab and Erlotinib as a second-line therapy for advanced hepatocellular carcinoma.. Onco Targets Ther. 2016, Feb; 15(9): 773-80. Cited in PubMed; PMID: 26929648. Pub Status: Published.

Abaza, Y., Abdel-Wahab, R., Li, D., Kaseb, A.O., Wolff, R.A., Raghav, K., Shalaby, A., Sahin, I.H., Morris, J., Hawk, E., Phan, A.T., Patt, Y.Z., & Hassan, M. Association between the job types and the risk of hepatocellular carcinoma in the United States. Journal of Epidemiological research. 2016, Aug; 3(1): E-pub. Pub Status: Published.

Kaseb, A.O., Hassan, M., Lacin, S., Abdel-Wahab, R., Amin, H.M., Shalaby, A., Wolff, R.A., Yao, J., Rashid, A., Vennapusa, B., Feng, J., & Ohtomo, T. Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma. Oncotarget. 2016, Oct; 7(43): 69916-69926. Cited in PubMed; PMID: 27655712. Pub Status: Published.

Abdel-Wahab, R., Hassan, M., Raghav, K.P., Shalaby, A., Botrus, G., Xiao, L., Morris, J., Wolff, R.A., & Kaseb, A.O. Single institutional experience of bevacizumab-based regimens in treatment of hepatocellular carcinoma. Journal of Clinical Oncology. 2015, May; 33(15): E-pub. Pub Status: Published.

Hassan, M.M., Abdel-Wahab, R., Kaseb, A., Shalaby, A., Phan, A.T., El-Serag, H.B., Hawk, E., Morris, J., Singh Raghav, K.P., Lee, J.S., Vauthey, J.N., Bortus, G., Torres, H.A., Amos, C.I., Wolff, R.A., & Li, D.. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015, Jul; 149(1): 119-29. Cited in PubMed; PMID: 25836985. Pub Status: Published.




I enjoy cooking Mediterranean meals, exploring thrift stores, reading biographies, traveling, and spending time with my family and dog